TerrAscend Corp. (TSNDF)
OTCMKTS · Delayed Price · Currency is USD
0.8510
+0.0990 (13.16%)
Sep 5, 2025, 4:00 PM EDT
TerrAscend Market Cap
TerrAscend has a market cap or net worth of $263.46 million as of September 5, 2025. Its market cap has decreased by -39.29% in one year.
Market Cap
263.46M
Enterprise Value
475.42M
Revenue
299.52M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.85
Market Cap Chart
Since May 3, 2017, TerrAscend's market cap has increased from 25.82M to 263.46M, an increase of 920.47%. That is a compound annual growth rate of 32.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 5, 2025 | 263.46M | 41.57% |
| Dec 31, 2024 | 186.10M | -61.11% |
| Dec 29, 2023 | 478.56M | 61.26% |
| Dec 30, 2022 | 296.76M | -74.68% |
| Dec 31, 2021 | 1.17B | -24.29% |
| Dec 31, 2020 | 1.55B | 398.32% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| May 3, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 825.37M |
| Elite Pharmaceuticals | 749.52M |
| Tian'an Technology Group | 705.53M |
| Glass House Brands | 600.00M |
| HealthLynked | 499.79M |
| CytoDyn | 396.74M |
| Northwest Biotherapeutics | 376.41M |